Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-03-14
1987-03-24
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, 544273, C07D47308, A61K 3152
Patent
active
046525688
ABSTRACT:
A novel theophylline-7- acetic acid ester is described. Said ester is obtained by reacting, at a temperature from 1.degree. to 20.degree. C., theophylline-7-acetic acid chloride with d,l-trans-sobrerol.
There are further described pharmaceutical compositions with mucosecretolytic-fluidizing and antibronchospastic activity containing the novel ester.
REFERENCES:
patent: 2756229 (1956-07-01), Stoll et al.
patent: 3632742 (1972-01-01), Eckat et al.
patent: 4120947 (1978-10-01), Diamond
Camillo Corvi S.p.A.
Rizzo Nicholas S.
LandOfFree
Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1354155